These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1347965)

  • 21. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous fenoldopam in heart failure: comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprusside.
    Young JB; Leon CA; Pratt CM; Kingry C; Taylor AA; Roberts R
    Am Heart J; 1988 Feb; 115(2):378-84. PubMed ID: 2893527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction.
    Eleid MF; Nishimura RA; Sorajja P; Borlaug BA
    Circulation; 2013 Sep; 128(12):1349-53. PubMed ID: 23956211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis.
    Bodmann KF; Tröster S; Clemens R; Schuster HP
    Clin Investig; 1993 Dec; 72(1):60-4. PubMed ID: 7907900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group.
    Panacek EA; Bednarczyk EM; Dunbar LM; Foulke GE; Holcslaw TL
    Acad Emerg Med; 1995 Nov; 2(11):959-65. PubMed ID: 8536121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous fenoldopam infusion in severe heart failure.
    Patel JJ; Mitha AS; Sareli P; de Vaal JB
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):97-101. PubMed ID: 8097927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with intravenous fenoldopam.
    Holcslaw TL; Beck TR
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preservation of renal blood flow during hypotension induced with fenoldopam in dogs.
    Aronson S; Goldberg LI; Roth S; Glock D; Moss J; Roizen MF
    Can J Anaesth; 1990 Apr; 37(3):380-4. PubMed ID: 1969772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.
    Cregeen RJ; Rudge PJ; Mills JG; Vincent SH; Burland WL
    J Hypertens Suppl; 1985 Dec; 3(3):S173-5. PubMed ID: 2908814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degree of external force to the left ventricle determines hemodynamic response to nitroprusside in failing hearts: comparison with the response to dobutamine.
    Yamamoto K; Masuyama T; Nagano R; Doi Y; Naito J; Mano T; Kondo H; Hori M; Kamada T
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):596-602. PubMed ID: 8569221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of prostaglandin I2 analogues on left ventricular diastolic function in vivo.
    Kisch-Wedel H; Kemming G; Meisner F; Flondor M; Bruhn S; Koehler C; Messmer K; Zwissler B
    Eur J Pharmacol; 2005 Jul; 517(3):208-16. PubMed ID: 15993879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.
    Brogden RN; Markham A
    Drugs; 1997 Oct; 54(4):634-50. PubMed ID: 9339965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung.
    Polak MJ; Taylor DA
    Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of a specific dopaminergic receptor agonist with metoclopramide in horses.
    Eades SC; Moore JN
    Am J Vet Res; 1993 Jan; 54(1):122-5. PubMed ID: 8093992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion.
    Paulus WJ; Vantrimpont PJ; Shah AM
    Circulation; 1994 May; 89(5):2070-8. PubMed ID: 7910117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular and renal profile of acute peripheral dopamine1-receptor agonism with fenoldopam.
    Glück Z; Jossen L; Weidmann P; Gnädinger MP; Peheim E
    Hypertension; 1987 Jul; 10(1):43-54. PubMed ID: 2885268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A preliminary study of the dopamine DA1 agonist fenoldopam in the treatment of chronic left ventricular failure due to ischaemic heart disease.
    MacDonald TM; Jeffrey RF; Muir AL; Lee MR
    Eur J Clin Pharmacol; 1990; 38(2):199-201. PubMed ID: 1970961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.
    Taylor AA; Shepherd AM; Polvino W; Mangoo-Karim R; Ballard K; Sunthornyothin S; Luther RR; Pool JL
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):906-14. PubMed ID: 10509549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.